ENVB
Price:
$0.3333
Market Cap:
$3.31M
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.[Read more]
Industry
Biotechnology
IPO Date
2015-05-04
Stock Exchange
NASDAQ
Ticker
ENVB
According to Enveric Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -201.01%. This represents a change of 271.46% compared to the average of -54.11% of the last 4 quarters.
The mean historical ROE of Enveric Biosciences, Inc. over the last ten years is -67.59%. The current -201.01% ROE has changed 197.41% with respect to the historical average. Over the past ten years (40 quarters), ENVB's ROE was at its highest in in the December 2014 quarter at 276.34%. The ROE was at its lowest in in the December 2021 quarter at -188.76%.
Average
-67.59%
Median
-89.33%
Minimum
-731.34%
Maximum
869.13%
Discovering the peaks and valleys of Enveric Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 109.09%
Maximum Annual ROE = 869.13%
Minimum Annual Increase = -184.15%
Minimum Annual ROE = -731.34%
Year | ROE | Change |
---|---|---|
2023 | -0.88% | -99.30% |
2022 | -125.90% | -42.66% |
2021 | -219.57% | 17.42% |
2020 | -186.99% | 254.42% |
2019 | -52.76% | -66.41% |
2018 | -157.05% | 236.52% |
2017 | -46.67% | 95.70% |
2016 | -23.85% | -96.74% |
2015 | -731.34% | -184.15% |
2014 | 869.13% | 109.09% |
The current ROE of Enveric Biosciences, Inc. (ENVB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-115.45%
5-year avg
-117.22%
10-year avg
-67.59%
Enveric Biosciences, Inc.’s ROE is less than Ocean Biomedical, Inc. (64.85%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), greater than Elevation Oncology, Inc. (-59.73%), less than AVROBIO, Inc. (29.68%), greater than CohBar, Inc. (-58.44%), greater than Zura Bio Limited (-39.61%), less than eFFECTOR Therapeutics, Inc. (2.18%),
Company | ROE | Market cap |
---|---|---|
64.85% | $24.95M | |
-505.74% | $4.62M | |
-59.73% | $35.67M | |
29.68% | $5.24M | |
-58.44% | $1.45M | |
-39.61% | $178.25M | |
2.18% | $941.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enveric Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enveric Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Enveric Biosciences, Inc.'s ROE?
How is the ROE calculated for Enveric Biosciences, Inc. (ENVB)?
What is the highest ROE for Enveric Biosciences, Inc. (ENVB)?
What is the 3-year average ROE for Enveric Biosciences, Inc. (ENVB)?
What is the 5-year average ROE for Enveric Biosciences, Inc. (ENVB)?
How does the current ROE for Enveric Biosciences, Inc. (ENVB) compare to its historical average?